Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 3,745 shares at $79.15 ($297K) on 2021-06-02, disclosed to the SEC on 2021-06-03.
Open-market sale of $297k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.99 | 1,255 | $100K | 33.7% |
| 2 | $79.15 | 1,245 | $99K | 33.1% |
| 3 | $79.15 | 1,245 | $99K | 33.1% |
| Total | $79.43 avg | 3,745 | $297K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |